Abstract
Verapamil and gynipral administered to pregnant rats in doses on a clinical level suppress the uterine contractions, which is manifested by a decrease in the amplitude and frequency of the biopotential. The joint administration of gynipral and verapamil (in half doses) resulted in a pronounced tocolytic effect.
MeSH terms
-
Adrenergic beta-Agonists / pharmacology*
-
Animals
-
Calcium Channel Blockers / pharmacology*
-
Drug Synergism
-
Female
-
Hexoprenaline / pharmacology*
-
Myometrium / physiology
-
Pregnancy
-
Rats
-
Rats, Wistar
-
Tocolytic Agents / pharmacology*
-
Uterine Contraction / drug effects*
-
Verapamil / pharmacology*
Substances
-
Adrenergic beta-Agonists
-
Calcium Channel Blockers
-
Tocolytic Agents
-
Verapamil
-
Hexoprenaline